IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
17 hedge funds and large institutions have $5.66M invested in Interpace Biosciences, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$344K | |
| 2 | +$40K | |
| 3 | +$26K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$23K |
| 5 |
AF
Allworth Financial
Folsom,
California
|
+$11K |
Top Sellers
| 1 | -$471K | |
| 2 | -$24K | |
| 3 | -$23K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$12K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1K |